LCMS for identification of all HCPs in a sample requires complex and time-consuming analytics, as you indicate. Are there upcoming advances in software/AI/instrumentation that may simplify this (outside of targeted LCMS)?
DIA LC-MS in our opinion is the best approach for un-targeted ID and Quant of all HCPs in a sample.
Ejvind Mørtz, PhD, Co-Founder & COO of Alphalyse in Denmark, discusses the regulatory expectations for HCP analysis, highlighting the importance of USP <1132.1> to improve MS-based data quality. Don’t miss his presentation and expert insights at the panel discussion.
Watch the On-Demand presentation here: https://bio-qc.com/regulatory-expectations-for-your-hcp-analysis-meet-usp-1132-1-to-enhance-the-quality-of-ms-based-data/
Advertisement
Advertisement
Advertisement